On August 15, 2023, the Minister of Health announced the appointment of Anie Perrault as Vice Chairperson of the Patented Medicine Prices Review Board (PMPRB) for a five-year term. According to the announcement, Ms. Perrault has over 30 years of experience in the public and private sectors, having held positions in the genomic research and biotechnology sector in Quebec and nationally.
On August 22, 2023, the PMPRB published the seventh edition of its annual Meds Entry Watch report, which explores the market entry of new medicines in Canada and other countries. The 2023 report examines trends in new medicine approvals and sales internationally and in Canada from 2016-2021, with a focus on medicines approved in 2020 and 2021.
Related Publications & Articles
-
Health Canada publishes guidance on distinction between advertising and other activities for health products
Promotional messages and activities regarding a health product are subject to the advertising provisions under the Food and Drugs Act (FDA), the Controlled Drugs and Substances Act and/or their associ...Read More -
Updated and new draft Health Canada guidance documents related to medical devices
On August 30, 2023, Health Canada opened consultation on its draft pre-market guidance for machine learning-enabled medical devices (MLMD).Read More -
pCPA appoints Douglas Clark as its first CEO
The pan-Canadian Pharmaceutical Alliance (pCPA) has appointed Douglas Clark as the pCPA’s first CEO, effective September 11, 2023.Read More